Neurobehavioral effects of prenatal exposure to AZT: A preliminary investigation with the D1 receptor agonist SKF 38393 in mice

Neurotoxicology and Teratology

Volumn 27, Issue 1, 2005, Pages 169-173

  Venerosi, Aldina ^a   Valanzano, Angelina ^a   Puopolo, Maria ^a   Calamandrei, Gemma ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

AZT; Dopamine receptors; Grooming; SKF 38393

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; SODIUM CHLORIDE; ZIDOVUDINE;

ANIMAL EXPERIMENT; ARTICLE; AUTOMATION; BEHAVIOR; CENTRAL NERVOUS SYSTEM; COGNITION; DOPAMINERGIC SYSTEM; FEMALE; GROOMING; LIFESPAN; MALE; MOUSE; NONHUMAN; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; ANIMALS, NEWBORN; ANTI-HIV AGENTS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPISTASIS, GENETIC; EXPLORATORY BEHAVIOR; FEMALE; GROOMING; MALE; MICE; MOTOR ACTIVITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RECEPTORS, DOPAMINE D1; STATISTICS, NONPARAMETRIC; ZIDOVUDINE;

ANIMALIA;

EID: 12844262869     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2004.09.008     Document Type: Article

References (21)

1. L.E. AppleWhite-Black, D. Dow-Edwards, and H.L. Minkoff Neurobehavioural and pregnancy effects of prenatal zidovudine exposure in Sprague-Dawley rats: preliminary findings Neurotoxicol. Teratol. 20 1998 251 258
2. S. Blanche, M. Tardieu, P. Rustin, A. Slama, B. Barret, G. Firtion, N. Ciraru-Vigneron, C. Lacroix, C. Rouzioux, L. Mandelbrot, I. Desguerre, A. Rotig, M.J. Mayaux, and J.F. Delfraissy Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues Lancet 354 1999 1084 1089
3. K. Brinkman, J.M. Hadewych, D.M. Burger, J.A.M. Smetink, and P.P. Koopmans Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway AIDS 12 1998 1735 1744
4. G. Calamandrei, A. Venerosi, I. Branchi, F. Chiarotti, A. Verdina, F. Bucci, and E. Alleva Effects of prenatal AZT on mouse neurobehavioral development and passive avoidance learning Neurotoxicol. Teratol. 21 1999 29 40
5. G. Calamandrei, O. Rufini, A. Valanzano, and M. Puopolo Long-term effects of developmental exposure to zidovudine on exploratory behavior and novelty discrimination in CD-1 mice Neurotoxicol. Teratol. 24 2002 529 540
6. G. Calamandrei, A. Valanzano, M. Puopolo, and L. Aloe Developmental exposure to the antiretroviral drug zidovudine increases brain levels of brain-derived neurotrophic factor in mice Neurosci. Lett. 333 2002 111 114
7. CDC Centers for Disease Control, Public Health Service task force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal transmission in the United States Morb. Mortal. Wkly. Rep. 47 1998 1 28
8. E.M. Connor, R.S. Sperling, R. Gelber, P. Kiselev, G. Scott, M.J. O'Sullivan, R. VanDyke, M. Bey, W. Shearer, R.L Jacobson, E. Jimenez, E.B. O'Neill, J.F. BazinDelfraissy, M. Culnane, R. Coombs, M. Elkins, J. Moye, P. Stratton, and J. Balsley Reduction of maternal-infant trasmission of human immunodeficiency virus type 1, with zidovudine treatment N. Engl. J. Med. 331 1994 1173 1180
9. M. Culnane, M. Fowler, S.S. Lee, G. McSherry, M. Brady, K. O'Donnell, L. Mofenson, S.L. Gortmaker, D.E. Shapiro, G. Scott, E. Jimenez, E.C. Moore, C. Diaz, P.M. Flynn, B. Cunningham, J. Oleske Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women JAMA 28 1999 151 157
10. H. Fang, J. Chartier, C. Sodja, A. Desbois, M. Ribecco-Lutkiewicz, P.R. Walker, and M. Sikorska Transcriptional activation of the human brain-derived neurotrophic factor gene promoter III by dopamine signaling in NT2/N neurons J. Biol. Chem. 278 2003 26401 26409
11. M.B. Heaton, J.J. Mitchell, M. Paiva, and D.W. Walker Ethanol-induced alterations in the expression of neurotrophic factors in the developing rat central nervous system Dev. Brain Res. 121 2000 97 107
12. R.R. Holson, and B. Pearce Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species Neurotoxicol. Teratol. 14 1992 221 228
13. C. Hyman, M. Hofer, Y.A. Barde, M. Juhasz, G.D. Yancopoulos, S.P. Squinto, and R.M. Lindsay BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra Nature 350 1991 230 232
14. A. Landreau-Mascaro, B. Barret, M.J. Mayaux, M. Tardieu, and S. Blanche Risk of early febrile seizure with perinatal exposure to nucleoside analogues Lancet 359 2002 583 584
15. A.G. Molloy, and J.L. Waddington Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390 Psychopharmacology (Berl) 82 1984 409 410
16. B.S. Starr, and M.S. Starr Differential effects of dopamine D1 and D2 agonists and antagonists on velocity of movement, rearing and grooming in the mouse. Implications for the roles of D1 and D2 receptors Neuropharmacology 25 1986 455 463
17. B.S. Starr, and M.S. Starr Behavioural interactions involving D1 and D2 dopamine receptors in non-habituated mice Neuropharmacology 26 1987 613 619
18. P. Tandon, Y. Yang, K. Das, G.L. Holmes, and C.E. Stafstrom Neuroprotective effects of brain-derived neurotrophic factor in seizures during development Neuroscience 91 1999 293 303
19. J.L. Venero, B. Knusel, K.D. Beck, and F. Hefti Expression of neurotrophin and trk receptor genes in adult rats with fimbria transections: effect of intraventricular nerve growth factor and brain-derived neurotrophic factor administration Neuroscience 59 1994 797 815
20. A. Venerosi, F. Cirulli, I.G. Lil'p, M. Fiore, G. Calamandrei, and E. Alleva Prolonged perinatal exposure to AZT affects aggressive behavior of adult CD-1 mice Psychopharmacology 150 2000 404 411
21. A. Venerosi, F. Cirulli, F. Capone, and E. Alleva Prolonged perinatal AZT administration and early maternal separation: effects on social and emotional behaviour of periadolescent mice Pharmacol. Biochem. Behav. 74 2003 671 681